Biohaven

Biohaven is a biopharmaceutical company dedicated to the discovery, development, and commercialization of life-changing treatments in key therapeutic areas including neuroscience, immunology, and oncology. The company is driven by a patient-first culture, operating with urgency and intention to turn groundbreaking scientific discoveries into best-in-class therapies for diseases with limited or no treatment options. They are committed to challenging the status quo and disrupting the traditional approach to treating diseases, particularly rare disorders.

Biohaven boasts a robust pipeline of drug candidates across various disease areas, including migraine, obsessive-compulsive disorder, epilepsy, and spinal muscular atrophy. They leverage their proprietary drug development platforms, including their next-generation bispecific technology, to rapidly generate novel therapies. The company is also known for its collaborative approach, working with global leaders in scientific discovery and medicine to expand their reach and address unmet medical needs worldwide.

Biohaven offers a flexible work environment, including Flex Fridays where employees have a lighter schedule on Friday afternoons. While details about remote work arrangements are not explicitly mentioned, the company's emphasis on a decentralized leadership structure and cross-functional teams suggest a degree of autonomy and flexibility in how employees organize their work.

Biohaven offers a comprehensive benefits package for US-based employees, prioritizing health and well-being. This includes 100% employer-paid medical, dental, vision, and life insurance, as well as short-term and long-term disability coverage. Employees can also take advantage of a lifestyle spending account for fitness and wellness initiatives. Additionally, Biohaven provides a retirement program and an employee stock purchase plan, allowing employees to own a piece of the company's success and build wealth. Finally, Biohaven offers "Flex Fridays," providing a lighter work schedule to promote work-life balance.

Biohaven is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments for diseases with significant unmet medical needs, particularly in neuroscience, immunology, and oncology. They operate with urgency and intention, leveraging cutting-edge science to turn breakthrough discoveries into best-in-class therapies for diseases with limited or no existing treatment options. Their mission is to improve lives by providing innovative medicines that address the most challenging diseases.

Biohaven promotes a culture that values innovation, collaboration, and agility. The company encourages employees to share their ideas, challenge the status quo, and work together to achieve ambitious goals. This non-hierarchical environment fosters a sense of ownership and empowers employees to make decisions and drive value. Biohaven is a patient-centric organization, and this commitment to improving lives permeates the culture, driving a sense of urgency and dedication to developing transformative therapies.

Biohaven is committed to fostering a diverse, equitable, and inclusive work environment where all employees feel valued and respected. They actively seek out and support individuals from underrepresented groups, striving to create a culture of collaboration and innovation where every voice is heard and valued. Their decentralized leadership structure empowers individuals to contribute their unique perspectives and talents, fostering a sense of belonging and encouraging everyone to do their best work.